They've been talking about having the second Phase 3 ready to go regardless of the FDA decision for months. And when the didn't hold a conference call with earnings it was obvious. No surprises here, yawn. Not much has changed, except you can now buy TTPH at a 50% discount to book value. Probably making it official is what the stock needed to begin moving up against to fair value. GLTA
Look it up on google. This company is rubbish and barely worth the office equipment and space it occupies in Cambridge. In situations like yesterday, Class Action Lawsuits and Dilution typically drive the final nail into the coffin before bankruptcy.
Your surgeon takes a tumor out. Sends it to hospital pathology lab. They send back a report. Oncologist makes a treatment decision based on studies, experience, trial and error. In comes FMI, your oncologist could send it to them, they analyze then using a huge database of information and gene profiling sends back a detailed report with best treatment regimens to maximize your odds of survival. Getting it right the first time also reduces cost. Called precision medicine. Buy all you can. This where medicine is heading.